Financial Update

• Revenue Growth: Revenue increased by 6.06% for the year ended March 31, 2025.
• Net Profit: Decreased by 37.14% to Rs. 6,062.82 million.
• Cash Flow: Net cash flow from operating activities was Rs. 3,178.88 million.
• Share Price: Volatile, ranging from Rs. 1,000 to Rs. 1,500 in the last year.
• EPS: Decreased by 37.14% to Rs. 110.05 million.

Key Business Highlights

• Appointment of Secretarial Auditor: M/s Manish Ghia & Associates.
• Financial Results: Audited financial results for the year ended March 31, 2025.
• Business Segments: Single operating segment, the Care Enablement platform.

What This Means for You

• Be cautious of declining net profit and cash flow from operating activities.
• Consider the company's volatile share price movement and associated risks.

Financial Highlights

• Revenue growth of 17% YoY in Q4 FY25
• EBITDA up 68% YoY, 13% QoQ
• PAT up 133% YoY, 14% QoQ
• Adjusted PAT up 108% YoY, 13% QoQ

Business Highlights

• Five prominent client wins, including three platform deals
• Strategic partnerships with notable industry players

What This Means for You

• Strong revenue growth and margin expansion are positive signs.
• However, future growth prospects are subject to risks and uncertainties.

Summary

• GI Alliance partners with IKS Health to deploy AI-enabled technology for Revenue Cycle Management (RCM) in GI and GI-allied specialties.
• The collaboration aims to reduce administrative tasks and improve patient care for GI Alliance clinicians and staff.

What This Means for You

• This partnership may lead to increased efficiency and better patient care for GI Alliance, but also increases their reliance on IKS Health's technology.
• IKS Health may benefit from the partnership, but faces integration challenges and potential dependence on GI Alliance.